Suture line administration technique using botulinum toxins

Details for Australian Patent Application No. 2009231786 (hide)

Owner Allergan, Inc.

Inventors Blumenfeld, Andrew M.

Agent Davies Collison Cave

Pub. Number AU-A-2009231786

PCT Pub. Number WO2009/124046

Priority 12/062,372 03.04.08 US

Filing date 31 March 2009

Wipo publication date 8 October 2009

International Classifications

A61K 38/48 (2006.01) Medicinal preparations containing peptides

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

Event Publications

28 October 2010 PCT application entered the National Phase

  PCT publication WO2009/124046 Priority application(s): WO2009/124046

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009231788-Tinted silicone ophthalmic devices, processes and polymers used in the preparation of same

2009231779-System and method of iris-pupil contrast enhancement